Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Matrix metalloproteinase-10 (MMP-10) interaction with tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2: binding studies and crystal structure.

Batra J, Robinson J, Soares AS, Fields AP, Radisky DC, Radisky ES.

J Biol Chem. 2012 May 4;287(19):15935-46. doi: 10.1074/jbc.M112.341156. Epub 2012 Mar 16.

2.

Matrix metalloproteinase-10/TIMP-2 structure and analyses define conserved core interactions and diverse exosite interactions in MMP/TIMP complexes.

Batra J, Soares AS, Mehner C, Radisky ES.

PLoS One. 2013 Sep 20;8(9):e75836. doi: 10.1371/journal.pone.0075836. eCollection 2013.

3.
4.

Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition.

Lee MH, Rapti M, Knaüper V, Murphy G.

J Biol Chem. 2004 Apr 23;279(17):17562-9. Epub 2004 Jan 20.

6.
7.

Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors.

Hamze AB, Wei S, Bahudhanapati H, Kota S, Acharya KR, Brew K.

Protein Sci. 2007 Sep;16(9):1905-13. Epub 2007 Jul 27.

8.
9.
10.
11.

Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.

Gomis-Rüth FX, Maskos K, Betz M, Bergner A, Huber R, Suzuki K, Yoshida N, Nagase H, Brew K, Bourenkov GP, Bartunik H, Bode W.

Nature. 1997 Sep 4;389(6646):77-81.

PMID:
9288970
12.

Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2.

Morgunova E, Tuuttila A, Bergmann U, Tryggvason K.

Proc Natl Acad Sci U S A. 2002 May 28;99(11):7414-9.

13.

Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.

Fernandez-Catalan C, Bode W, Huber R, Turk D, Calvete JJ, Lichte A, Tschesche H, Maskos K.

EMBO J. 1998 Sep 1;17(17):5238-48.

14.
15.

Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation.

Zhao H, Bernardo MM, Osenkowski P, Sohail A, Pei D, Nagase H, Kashiwagi M, Soloway PD, DeClerck YA, Fridman R.

J Biol Chem. 2004 Mar 5;279(10):8592-601. Epub 2003 Dec 16.

16.
17.

MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues.

Birkedal-Hansen B, Pavelic ZP, Gluckman JL, Stambrook P, Li YQ, Stetler-Stevenson WG.

Oral Dis. 2000 Nov;6(6):376-82.

PMID:
11355270
18.

TIMP-1 contact sites and perturbations of stromelysin 1 mapped by NMR and a paramagnetic surface probe.

Arumugam S, Hemme CL, Yoshida N, Suzuki K, Nagase H, Berjanskii M, Wu B, Van Doren SR.

Biochemistry. 1998 Jul 7;37(27):9650-7.

PMID:
9657677
19.

Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat.

Knittel T, Mehde M, Grundmann A, Saile B, Scharf JG, Ramadori G.

Histochem Cell Biol. 2000 Jun;113(6):443-53.

PMID:
10933221
20.

Flexibility and variability of TIMP binding: X-ray structure of the complex between collagenase-3/MMP-13 and TIMP-2.

Maskos K, Lang R, Tschesche H, Bode W.

J Mol Biol. 2007 Mar 2;366(4):1222-31. Epub 2006 Dec 1.

PMID:
17196980
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk